Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,445 total articles

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix, a Nasdaq-listed biotechnology firm, is set to acquire Realbotix LLC, a company specializing in AI-powered humanoid robots. Realbotix recently secured an agreement to have one of its humanoid robots featured as a character in a popular Emmy-award-winning streaming series. This development highlights Realbotix's expanding presence across e…

Onfolio Holdings Announces 1-For-50 Reverse Stock Split To Regain Nasdaq Compliance; Reducing Float To Approximately 850,000 Shares

Onfolio Holdings Announces 1-For-50 Reverse Stock Split To Regain Nasdaq Compliance; Reducing Float To Approximately 850,000 Shares

Onfolio Holdings, Inc. is implementing a 1-for-50 reverse stock split effective August 10, 2026, to increase its stock price above $1.00 and regain compliance with Nasdaq listing rules. This corporate action will reduce the outstanding shares from approximately 42 million to 850,000 shares. The company's ticker will remain ONFO, and trading will co…

Cloudastructure Wins Full Guard Replacement Across Five-Building Southern California Office Portfolio for One of the World's Largest Commercial Real Estate Firms

Cloudastructure Wins Full Guard Replacement Across Five-Building Southern California Office Portfolio for One of the World's Largest Commercial Real Estate Firms

Cloudastructure, Inc. announced the deployment of its AI Surveillance and Remote Guarding platform to fully replace onsite security guards across a five-building commercial office portfolio in Southern California. The implementation will establish new camera surveillance infrastructure, expanding Cloudastructure's presence in commercial real estate…

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

RenovoRx announced the first commercial clinical use of its FDA-cleared drug-delivery device, RenovoCath, for treating a sarcoma patient, marking a significant expansion of the device's application beyond pancreatic cancer to other solid tumors. Treatment at CARTI Cancer Center involves localized chemotherapy delivery near the tumor, potentially re…

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc., a Nasdaq-listed online marketplace connecting scientists with biospecimens for medical research, announced the pricing of a $5 million public offering of common stock and pre-funded warrants at $1.30 per share. Proceeds will be used to repay liabilities, possibly acquire assets, invest in business and marketing activities, and for w…

Stran & Company Schedules Second Quarter 2026 Financial Results and  Business Update Conference Call

Stran & Company Schedules Second Quarter 2026 Financial Results and Business Update Conference Call

Stran & Company, a leading outsourced marketing solutions provider specializing in promotional products and loyalty incentive programs, announced a conference call on August 12, 2026, to discuss its second quarter 2026 financial results and corporate developments. The call will feature insights into the company’s business progress and strategic ini…

Arteris Appoints Saurabh Sinha as Chief Financial Officer

Arteris Appoints Saurabh Sinha as Chief Financial Officer

Arteris, a semiconductor technology company specialized in network-on-chip interconnect IP, has appointed Saurabh Sinha as its new Chief Financial Officer effective September 8, 2026. Sinha replaces Nick Hawkins, who is retiring after seven years and will assist with the transition in an advisory capacity. Sinha brings extensive financial leadershi…

The Metals Company Announces Second Quarter 2026 Corporate Update Conference Call for Thursday, August 13, 2026

The Metals Company Announces Second Quarter 2026 Corporate Update Conference Call for Thursday, August 13, 2026

The Metals Company Inc. announced it will host a conference call on August 13, 2026, to discuss its second quarter 2026 financial results and recent corporate developments. The company is involved in developing critical metals from seafloor polymetallic nodules, focusing on supplying metals with lower environmental impact and advancing recycling ef…

Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

Vistagen announced positive topline results from its Phase 2 repeat dose study evaluating fasedienol nasal spray for acute treatment of social anxiety disorder (SAD). The study showed favorable safety and tolerability, with numerical improvements over placebo on primary and secondary efficacy endpoints, particularly in patients with very severe SAD…

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Propanc Biopharma announced highly encouraging preclinical data for its lead candidate PRP in treating pancreatic ductal adenocarcinoma, showing over 90% tumor growth inhibition, reduced metastasis, and more than 2.5-fold increase in median survival in animal models. The data supports PRP’s novel mechanism targeting cancer stem cells and tumor micr…

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

MiNK Therapeutics will report its Q2 2026 financial results and provide clinical updates on its off-the-shelf iNKT cell therapy agenT-797 targeting acute lung injury. The company will discuss new clinical data and the launch of a named-patient program, highlighting progress in treating pulmonary immune failure and other immune disorders.

AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

AZIO AI Secures Sales Pipeline for 128 NVIDIA HGX B300 Systems

AZIO AI Holdings, Inc. announced a significant sales agreement with Power Champion Investment Limited to supply up to 128 NVIDIA HGX B300 AI systems for deployment in U.S.-based AI infrastructure facilities. The deal potentially totals around $77 million in hardware value, reinforcing AZIO AI's growth in the AI infrastructure sector and expanding i…

Cargo Theft Losses More Than Double to $304 Million in Q2 Despite a Drop in Thefts, Driven by High-Value Metals and Technology Heists

Cargo Theft Losses More Than Double to $304 Million in Q2 Despite a Drop in Thefts, Driven by High-Value Metals and Technology Heists

Verisk's CargoNet business finds a 26% decline in cargo theft incidents in Q2 2026 compared with Q2 2025, but total financial losses more than doubled to $304.6 million driven by high-value metals and technology thefts. Declines in physical thefts and non-delivery fraud, especially in California and Texas, contrast with steady levels of compromise-…

Freshworks Achieves FedRAMP® "In Process" Designation for Freshservice, Advancing AI-Powered Service Operations for the Public Sector

Freshworks Achieves FedRAMP® "In Process" Designation for Freshservice, Advancing AI-Powered Service Operations for the Public Sector

Freshworks Inc. announced that Freshservice, its AI-powered service operations platform, has achieved FedRAMP In-Process designation for Class C (Moderate) certification. This milestone moves Freshservice closer to full FedRAMP authorization, enabling broader adoption across U.S. federal agencies and other government entities requiring high securit…

Banzai International, Inc. Unveils Agentic Platform Strategy, Plans to Change Its Name to Parabolic Technologies, Inc.

Banzai International, Inc. Unveils Agentic Platform Strategy, Plans to Change Its Name to Parabolic Technologies, Inc.

Banzai International, Inc. announced its plan to change its corporate name to Parabolic Technologies, Inc. following shareholder approval, reflecting a strategic pivot towards building and investing in AI-based agentic applications. The company will reorganize into three business units focused on AI sales acceleration, enterprise software, and AI-p…

Core AI Holdings Reports Strong Operational Execution Across AI Products, Data Intelligence and Growth Initiatives

Core AI Holdings Reports Strong Operational Execution Across AI Products, Data Intelligence and Growth Initiatives

Core AI Holdings, a Nasdaq-listed global AI technology firm, announced strong operational execution in the first half of 2026, achieving accelerated product milestones ahead of schedule and significant growth in user acquisition across its gaming portfolio. The company expanded its AI-driven analytics capabilities, improved internal reporting accur…

VivoSim Provides Financial and Listing Compliance Update

VivoSim Provides Financial and Listing Compliance Update

VivoSim Labs, a Nasdaq-listed biopharma services provider specializing in 3D human tissue models, announced regaining compliance with Nasdaq Listing Rule 5550(b)(1) following a $5 million milestone payment from Eli Lilly, additional escrow funds, and a $4 million equity financing. With cash on hand exceeding $10 million and a significant increase i…